Apogee Therapeutics, Inc. APGE Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s pre-tax income?
- Apogee Therapeutics, Inc. (APGE) reported pre-tax income of -$74.03M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Apogee Therapeutics, Inc.'s pre-tax income decreased by 34.0% year-over-year, from -$55.26M to -$74.03M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s pre-tax income?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s pre-tax income has grown at a 74.4% compound annual growth rate (CAGR), from -$83.99M to -$255.57M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.